QTI (38) IRIX (34) POCI (34) NDRA (48) ⌘ Pro Terminal →

iTonic Holdings Ltd (Class A) (ITOC) — RQD Stock Rating Cockpit

$2.85 -4.99% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)

iTonic Holdings Ltd (Class A) (ITOC) carries a Roarable Rating of D- (Sell) with 35/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D- • RED ALERT Cap $20.9M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERRED ALERT • D-

2-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk D

Each axis scored 0–20

12M PRICE TARGET CONE-10.2% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for ITOC)Realized 20D OHLCV Swing Band: ±12.5%

RSI-14 MOMENTUMNEUTRAL RANGE

32.930 Oversold · 70 Hot

ALTMAN-Z SHIELDFORTRESS SAFE (>3.0)

10.69>3.0 Fortress Safe

PIOTROSKI F-SCOREWEAK QUALITY (1–4)

4 / 99-Pt Accounting

52-WEEK LASER RANGE4% OF RANGE

L: $2$2.85H: $18

1. Money & Cash Health● WEAK

Are profits real cash in the bank?

Weak cash conversion or heavy valuation strain compared to actual cash earned.

Factor Grade: D-RQD 8 / 20

2. Big Money & Insiders● TRIMMING

Are whales & executives buying or selling?

Insiders and big institutional desks have been trimming shares rather than stepping up to buy.

Factor Grade: ERQD 7 / 40

3. Hidden Risks & Market Weather● WARNING

SEC fine-print scan & interest-rate fit

High sensitivity to tight interest rates or new risk warnings added to recent SEC annual filings.

Factor Grade: DRQD 20 / 40

MULTI-MODEL JEV QUANT JURY DELIBERATION

2-of-3 JEV AI Jury Bearish Warning on ITOC

Cash & Moat Bull AI

ROIC & Free Cash Flow Model

BEARISH (40)

-35.0% ROIC with 62.6% gross margin and -15.52% FCF yield.

SEC Forensic Auditor AI

10-K Accruals & Altman-Z Guard

BULLISH (70)

Altman-Z 10.69 and Piotroski 4/9 pass balance-sheet audit.

Whale & Macro Hawk AI

Options Skew, 13F & Fed NetLiq

BEARISH (22)

7/40 institutional & smart-money positioning score with 6/20 macro alignment.

Bull Case: Why Buyers Like ITOC

✓Established market leader in Health Care with deep daily trading liquidity.

Bear Case: What Could Go Wrong

!Company executives have done more routine share selling than personal cash buying lately.
!Sensitive to high interest rates and tighter Federal Reserve market liquidity.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring ITOC)

✓Walkthrough of ITOC's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

ITOC // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -50.95%⚡ TESTING RESISTANCE

2026-10-30O $2.45H $2.85L $2.12C $2.85VOL 39.4K

RES: $3.26SUP: $2.04SMA50: $4.25SMA200: $5.20

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

ITOC Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 ITOC Butterfly Map → + Track ITOC →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +16.7% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on ITOC today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for ITOC. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for ITOC today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (ITOC)

Health Care Rank #827 of 1016 ⚔️ QTI vs ITOC Full Matrix →

1. Head-to-Head Health Care Peer Comparison (ITOC vs. QTI, IRIX, POCI, NDRA)

Industry: Biotechnology: Electromedical & Electrotherapeutic Apparatus (26 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, iTonic Holdings Ltd (Class A) (ITOC) ranks #827 by composite RQD confidence (35/100, grade D-) and #830 by equity capitalization ($20.9M). Within this direct 5-issuer industry benchmark cohort, ITOC leads on earnings valuation at N/A trailing P/E, while ITOC leads on capital efficiency and profitability with -35.0% ROIC and 62.6% gross margin. NDRA currently holds the highest overall quantitative score in the immediate peer group at 48/100 (D) compared with ITOC at 35/100 (D-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
ITOC ACTIVE iTonic Holdings Ltd (Class A)	D-	35/100	—	62.6%	-35.0%	-4.99%	$20.9M	Benchmark Subject
QTI QT Imaging Holdings Inc.	D-	38/100	—	45.4%	-35.0%	-3.07%	$32.3M	/qti-vs-itoc →
IRIX IRIDEX Corporation	E	34/100	—	36.5%	-35.0%	-2.92%	$12.7M	/irix-vs-itoc →
POCI Precision Optics Corporation Inc.	E	34/100	—	17.8%	-35.0%	+5.76%	$50.5M	/poci-vs-itoc →
NDRA ENDRA Life Sciences Inc.	D	48/100	—	—	-35.0%	+2.95%	$7.3M	/ndra-vs-itoc →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001970544

In its most recent audited fiscal period (FY2025, filed 2025-12-31), iTonic Holdings Ltd (Class A) (ITOC) reported GAAP revenue of $523.0K (+16.7% vs. FY2024 revenue of $448.2K , and -16.8% cumulative change since FY2023) , GAAP net income of -$5.1M, operating cash flow of -$3.2M, and free cash flow of -$3.2M (-317.0% YoY). On the balance sheet, ITOC closed FY2025 with $9.1M in total assets against $0 in total debt (Altman Z-Score: 10.69, Piotroski F-Score: 4/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$523.0K	-$5.1M	-$3.2M	-$3.2M	$9.1M	—
FY2024 (FY)	2024-12-31	$448.2K	-$660.6K	-$775.0K	-$775.9K	$6.7M	—
FY2023 (FY)	2023-12-31	$628.6K	-$241.2K	-$63.6K	-$63.6K	—	—

3. ITOC Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is ITOC stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, iTonic Holdings Ltd (Class A) (NASDAQ: ITOC) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 35/100 at a spot price of $2.85 (-4.99% 1D, market cap $20.9M). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 4/20, Executive Insider Alignment 14/20, FRED Macro Regime Fit 6/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, ITOC ranks #827 in composite RQD confidence.

How does ITOC compare to QTI and IRIX in the Health Care sector?

Within the Health Care sector (Biotechnology: Electromedical & Electrotherapeutic Apparatus), ITOC carries a Roarable D- (35/100 RQD), trailing P/E of N/A, gross margin of 62.6%, and ROIC of -35.0%. By comparison, QTI (QT Imaging Holdings Inc.) holds a D- grade (38/100 RQD, P/E N/A, ROIC -35.0%, cap $32.3M) and IRIX (IRIDEX Corporation) posts a E grade (34/100 RQD, P/E N/A, ROIC -35.0%, cap $12.7M). Among the 5-stock peer group, ITOC leads on earnings multiple (N/A) while ITOC leads on capital efficiency (-35.0% ROIC).

What are the biggest fundamental strengths and SEC risk factors for ITOC?

Per ITOC's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001970544), iTonic Holdings Ltd (Class A) generated $523.0K in revenue (+16.7% YoY), -$5.1M in net income, and -$3.2M in free cash flow against $9.1M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is ITOC trading relative to its 50-day, 200-day, and 52-week technical levels?

ITOC last traded at $2.85 (-4.99% on volume of 4,938 shares), positioning the stock -32.94% below its 50-day simple moving average ($4.25) and -45.19% below its 200-day simple moving average ($5.20). Across its 52-week range of $2.12 to $18.40, ITOC sits at the 4.5% percentile with a 14-day RSI of 32.9 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($2.49 to $3.21).

ITOC Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Should I buy, hold, or sell ITOC stock right now?

iTonic Holdings Ltd (Class A) (ITOC) currently earns a Roarable Rating of D- (Sell — SELL) with 35/100 RQD Confidence. Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.

What is ITOC's 12-month price target and RQD AI Jury consensus?

ITOC's 12-month base price target is $2.56 (range $2 to $19.32), backed by transparent SEC XBRL cash-flow, Form 4 insider, and CBOE options flow analysis.

Direct Sub-Reports: ITOC RQD Cockpit ITOC 12M Forecast ITOC Earnings & Move ITOC Dividends & DRIP ITOC Insiders & 13F ITOC Whale Options ITOC Profit Sankey ITOC News & Why